Guangdong Nanxin Medical Technology

Guangdong Nanxin Medical Technology (also known as Guangdong Longsee Biomedical) is a Chinese biotechnology company founded in 2015 that specializes in human microecology, synthetic biology, and CRDMO services. The company leverages three strategic biological resources—including a massive strain bank of over 300,000 strains, fermented traditional Chinese medicine (TCM) base liquids, and a million-scale knowledge graph—alongside four proprietary R&D technology platforms to build an AI-powered end-to-end biomanufacturing infrastructure. Its diverse product and service portfolio spans novel food and pharmaceutical raw materials, live biotherapeutic products (LBPs), innovative TCM drugs, foods for special medical purposes (FSMPs), functional foods, specialty diagnostic and therapeutic service packages, and comprehensive CRDMO services. Headquartered in Guangzhou, China, Nanxin Medical operates multiple production bases and branches globally, serving over 300 medical institutions and 30 research institutes across more than 20 countries.